(Petzuch et al., 2022; Zabbarova et al., 2022) HA Ghofrani mainly studied the clinical application of sGC stimulators in CTEPH and PAH (Ghofrani et al., 2013a; Ghofrani et al., 2013b). Here, SGCB is linked to pulmonary arterial hypertension.